These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22134089)

  • 1. Transmembrane α-helix 2 and 7 are important for small molecule-mediated activation of the GLP-1 receptor.
    Rye Underwood C; Møller Knudsen S; Schjellerup Wulff B; Bräuner-Osborne H; Lau J; Knudsen LB; Peters GH; Reedtz-Runge S
    Pharmacology; 2011; 88(5-6):340-8. PubMed ID: 22134089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.
    Coopman K; Wallis R; Robb G; Brown AJ; Wilkinson GF; Timms D; Willars GB
    Mol Endocrinol; 2011 Oct; 25(10):1804-18. PubMed ID: 21868452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP.
    Chepurny OG; Matsoukas MT; Liapakis G; Leech CA; Milliken BT; Doyle RP; Holz GG
    J Biol Chem; 2019 Mar; 294(10):3514-3531. PubMed ID: 30622136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allostery.
    Koole C; Wootten D; Simms J; Miller LJ; Christopoulos A; Sexton PM
    J Pharmacol Exp Ther; 2015 Apr; 353(1):52-63. PubMed ID: 25630467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation.
    Koole C; Wootten D; Simms J; Miller LJ; Christopoulos A; Sexton PM
    J Biol Chem; 2012 Feb; 287(6):3642-58. PubMed ID: 22147710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist-induced internalisation of the glucagon-like peptide-1 receptor is mediated by the Gαq pathway.
    Thompson A; Kanamarlapudi V
    Biochem Pharmacol; 2015 Jan; 93(1):72-84. PubMed ID: 25449603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of glucagon-like peptide-1 receptor-binding determinants.
    Xiao Q; Jeng W; Wheeler MB
    J Mol Endocrinol; 2000 Dec; 25(3):321-35. PubMed ID: 11116211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity.
    Runge S; Wulff BS; Madsen K; Bräuner-Osborne H; Knudsen LB
    Br J Pharmacol; 2003 Mar; 138(5):787-94. PubMed ID: 12642379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A small molecule ligand of the glucagon-like peptide 1 receptor targets its amino-terminal hormone binding domain.
    Tibaduiza EC; Chen C; Beinborn M
    J Biol Chem; 2001 Oct; 276(41):37787-93. PubMed ID: 11498540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amino terminal domain of the glucagon-like peptide-1 receptor is a critical determinant of subtype specificity.
    Graziano MP; Hey PJ; Strader CD
    Recept Channels; 1996; 4(1):9-17. PubMed ID: 8723643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point mutations in the first and third intracellular loops of the glucagon-like peptide-1 receptor alter intracellular signaling.
    Heller RS; Kieffer TJ; Habener JF
    Biochem Biophys Res Commun; 1996 Jun; 223(3):624-32. PubMed ID: 8687446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery.
    Harikumar KG; Wootten D; Pinon DI; Koole C; Ball AM; Furness SG; Graham B; Dong M; Christopoulos A; Miller LJ; Sexton PM
    Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18607-12. PubMed ID: 23091034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of the endogenous agonist glucagon-like peptide-1 (GLP-1)-(7-36) amide and the small-molecule ago-allosteric agent "compound 2" at the GLP-1 receptor.
    Coopman K; Huang Y; Johnston N; Bradley SJ; Wilkinson GF; Willars GB
    J Pharmacol Exp Ther; 2010 Sep; 334(3):795-808. PubMed ID: 20507928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric modulation of the activity of the glucagon-like peptide-1 (GLP-1) metabolite GLP-1 9-36 amide at the GLP-1 receptor.
    Li N; Lu J; Willars GB
    PLoS One; 2012; 7(10):e47936. PubMed ID: 23094100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two small molecule agonists of glucagon-like peptide-1 receptor modulate the receptor activation response differently.
    Cheong YH; Kim MK; Son MH; Kaang BK
    Biochem Biophys Res Commun; 2012 Jan; 417(1):558-63. PubMed ID: 22177947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) differentially regulates orthosteric but not allosteric agonist binding and function.
    Koole C; Wootten D; Simms J; Savage EE; Miller LJ; Christopoulos A; Sexton PM
    J Biol Chem; 2012 Feb; 287(6):3659-73. PubMed ID: 22147709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain.
    Runge S; Schimmer S; Oschmann J; Schiødt CB; Knudsen SM; Jeppesen CB; Madsen K; Lau J; Thøgersen H; Rudolph R
    Biochemistry; 2007 May; 46(19):5830-40. PubMed ID: 17444618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R).
    Yang D; de Graaf C; Yang L; Song G; Dai A; Cai X; Feng Y; Reedtz-Runge S; Hanson MA; Yang H; Jiang H; Stevens RC; Wang MW
    J Biol Chem; 2016 Jun; 291(25):12991-3004. PubMed ID: 27059958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New screening strategy and analysis for identification of allosteric modulators for glucagon-like peptide-1 receptor using GLP-1 (9-36) amide.
    Nakane A; Gotoh Y; Ichihara J; Nagata H
    Anal Biochem; 2015 Dec; 491():23-30. PubMed ID: 26341912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors.
    Zhao LH; Yin Y; Yang D; Liu B; Hou L; Wang X; Pal K; Jiang Y; Feng Y; Cai X; Dai A; Liu M; Wang MW; Melcher K; Xu HE
    J Biol Chem; 2016 Jul; 291(29):15119-30. PubMed ID: 27226600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.